ACE (I/D) Genotype as a Predictor of the Magnitude and Duration of the Response to an ACE Inhibitor Drug (Enalaprilat) in Humans
- 17 November 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 98 (20), 2148-2153
- https://doi.org/10.1161/01.cir.98.20.2148
Abstract
Background—We have investigated the possible effects of contrasting ACE (I/D) genotypes on the responses to the ACE inhibitor enalaprilat in normotensive men. Methods and Results—Subjects with DD (...Keywords
This publication has 20 references indexed in Scilit:
- A Prospective Evaluation of an Angiotensin-Converting–Enzyme Gene Polymorphism and the Risk of Ischemic Heart DiseaseNew England Journal of Medicine, 1995
- Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme.Journal of Clinical Investigation, 1994
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Kinetic-dynamic relations and individual responses to enalapril.Hypertension, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Renin system activity as a determinant of response to treatment in hypertension and heart failure.Hypertension, 1983
- Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.BMJ, 1982
- Clinical use of an orally acting converting enzyme inhibitor: captopril.Hypertension, 1980
- A micro assay for active and total renin concentration in human plasma based on antibody trappingClinica Chimica Acta; International Journal of Clinical Chemistry, 1980